Is nalalizumab a breakthrough in the treatment of MS? Is nalalizumab a breakthrough in the treatment of MS?2018-01-17T17:05:43-05:00
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self2018-01-17T17:05:43-05:00
Omega–6/Omega–3 Ratio and Brain-Related Functions Omega–6/Omega–3 Ratio and Brain-Related Functions2018-01-17T17:05:43-05:00
Dietary Fat in Relation to Risk of Multiple Sclerosis among Two Large Cohorts of Women Dietary Fat in Relation to Risk of Multiple Sclerosis among Two Large Cohorts of Women2018-01-17T17:05:43-05:00
High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis2018-01-17T17:05:43-05:00
The initiation of the autoimmune response in multiple sclerosis The initiation of the autoimmune response in multiple sclerosis2018-01-17T17:05:43-05:00
Ultraviolet B but not A Radiation Activates Suppressor B Cells in Draining Lymph Nodes Ultraviolet B but not A Radiation Activates Suppressor B Cells in Draining Lymph Nodes2018-01-17T17:05:43-05:00
Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS2018-01-17T17:05:43-05:00
Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-up Study Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-up Study2018-01-17T17:05:43-05:00
Drug Interactions with Grapefruit Juice: An Evidence-Based Overview Drug Interactions with Grapefruit Juice: An Evidence-Based Overview2018-01-17T17:05:35-05:00
